About EpiCypher
EpiCypher is a company based in Chapel Hill (United States) founded in 2012. EpiCypher has raised $3.43 million across 45 funding rounds from investors including HHS. EpiCypher operates in a competitive market with competitors including Inherent Biosciences, Chronomics, Active Motif, Epiontis and Epigenica, among others.
- Headquarter Chapel Hill, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epicypher Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.43 M (USD)
in 45 rounds
-
Latest Funding Round
$1.27 M (USD), Grant
Sep 25, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EpiCypher
Unlock access to complete
Unlock access to complete
Funding Insights of EpiCypher
EpiCypher has successfully raised a total of $3.43M across 45 strategic funding rounds. The most recent funding activity was a Grant round of $1.27 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EpiCypher
EpiCypher has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for EpiCypher
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EpiCypher
Investment portfolio details for EpiCypher
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EpiCypher
Detailed financials for EpiCypher
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epicypher Comparisons
Peer comparison for EpiCypher
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EpiCypher
EpiCypher operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inherent Biosciences, Chronomics, Active Motif, Epiontis and Epigenica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Epigenetic diagnostics and therapeutics for complex diseases are developed.
|
|
| Locked | Locked | Locked |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
|
| Locked | Locked | Locked |
Epigenetics and gene regulation research tools are developed and distributed.
|
|
| Locked | Locked | Locked |
Develops epigenetic assays
|
|
| Locked | Locked | Locked |
Provider of solutions for the analysis of genomic data
|
Detailed competitors of EpiCypher
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epicypher
Complete news archive for EpiCypher
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EpiCypher
EpiCypher was founded in 2012 and raised its 1st funding round 1 year after it was founded.
EpiCypher is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
EpiCypher is a funded company, having raised a total of $3.43M across 45 funding rounds to date.
EpiCypher was founded in 2012 and is based in Chapel Hill, United States. Operations focus on the epigenetics sector, where kits, reagents, and assays are developed for research use. Products offered include antibodies, cell extracts, histone peptide arrays, histone peptides, nucleosomes, peptide synthesis services, and recombinant proteins. Cutana CUTRUN assays are also provided as an alternative to ChIP assays, enabling reduced cell input and broader target profiling.
EpiCypher's top competitors include Chronomics, Epigenica and Epiontis.
EpiCypher has 1 investor. Key investors include HHS.